These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4264668)
1. [Perianal skin changes caused by anthraquinone in laxatives]. Bergström G; Holst R Lakartidningen; 1972 Oct; 69():Suppl 3:28-9. PubMed ID: 4264668 [No Abstract] [Full Text] [Related]
2. [Perianal toxic contact dermatitis after use of the laxative Dorbantyl]. Hanssen LI; Nyfors A Tidsskr Nor Laegeforen; 1982 Nov; 102(32):1716. PubMed ID: 7167944 [No Abstract] [Full Text] [Related]
3. Erythema multiforme-like drug eruption caused by sennoside. Sugita K; Izu K; Tokura Y Int J Dermatol; 2006 Sep; 45(9):1123. PubMed ID: 16961536 [No Abstract] [Full Text] [Related]
8. [Acute skin damage caused by "X-prep"]. Helwig H; Mund H Monatsschr Kinderheilkd; 1986 Mar; 134(3):164. PubMed ID: 3702887 [No Abstract] [Full Text] [Related]
9. A cutaneous complication of Dorbanex therapy. Barth JH; Reshad H; Darley CR; Gibson JR Clin Exp Dermatol; 1984 Jan; 9(1):95-6. PubMed ID: 6229370 [No Abstract] [Full Text] [Related]
10. A case of interstitial granulomatous drug reaction due to sennoside. Fujita Y; Shimizu T; Shimizu H Br J Dermatol; 2004 May; 150(5):1035-7. PubMed ID: 15149527 [No Abstract] [Full Text] [Related]
11. Clinical and toxicological aspects of anthraquinone laxatives. Nelemans FA Pharmacology; 1976; 14 Suppl 1():73-7. PubMed ID: 981318 [No Abstract] [Full Text] [Related]
12. Adverse effects of laxatives: fact and fiction. Müller-Lissner SA Pharmacology; 1993 Oct; 47 Suppl 1():138-45. PubMed ID: 8234421 [TBL] [Abstract][Full Text] [Related]
13. A controlled trial of laxatives in geriatric patients. Christopher LJ Practitioner; 1969 Jun; 202(212):821-5. PubMed ID: 4894318 [No Abstract] [Full Text] [Related]
14. Letter: Red skin and dorbanex. Ippen H Br Med J; 1974 Nov; 4(5940):345. PubMed ID: 4434104 [No Abstract] [Full Text] [Related]
15. Problems caused by laxatives. Sarner M Practitioner; 1976 Jun; 216(1296):661-4. PubMed ID: 940795 [No Abstract] [Full Text] [Related]
16. [Participation in the expert forum "constipation and laxatives" 24 February 1999 in Vienna. Constipation and laxatives]. Praxis (Bern 1994); 1999 Aug; 88(31-32):1269-74. PubMed ID: 10479966 [No Abstract] [Full Text] [Related]
17. Anthraquinone laxatives and human cancer: an association in one case. Patel PM; Selby PJ; Deacon J; Chilvers C; McElwain TJ Postgrad Med J; 1989 Apr; 65(762):216-7. PubMed ID: 2594597 [TBL] [Abstract][Full Text] [Related]
18. Drug eruption due to sodium picosulfate. Ishikawa A; Sugiura K; Sato A; Muro Y; Akiyama M Eur J Dermatol; 2012; 22(3):410-1. PubMed ID: 22407128 [No Abstract] [Full Text] [Related]
19. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Kune GA Z Gastroenterol; 1993 Feb; 31(2):140-3. PubMed ID: 8465555 [TBL] [Abstract][Full Text] [Related]
20. Impressive picture of a melanosis coli after chronic anthraquinone laxative use--is there an increased risk for colorectal cancer? Abendroth A; Klein R; Schlaak J; Metz KA; Dobos GJ; Langhorst J Z Gastroenterol; 2009 Jun; 47(6):579-82. PubMed ID: 19533548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]